Skip to content
Open access · CC-BY via OpenAlex

Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis

Wenbin Liu, Yang Deng, Zishuai Li, Yifan Chen, Xiaoqiong Zhu, Xiaojie Tan, Guangwen Cao

Frontiers in Immunology · 2021 · ▲ 69 citations

Abstract

Chronic inflammation is a prerequisite for the development of cancers. Here, we present the framework of a novel theory termed as Cancer Evolution-Development (Cancer Evo-Dev) based on the current understanding of inflammation-related carcinogenesis, especially hepatocarcinogenesis induced by chronic infection with hepatitis B virus. The interaction between genetic predispositions and environmental exposures, such as viral infection, maintains chronic non-resolving inflammation. Pollution, metabolic syndrome, physical inactivity, ageing, and adverse psychosocial exposure also increase the risk of cancer via inducing chronic low-grade smoldering inflammation. Under the microenvironment of non-resolving inflammation, pro-inflammatory factors facilitate the generation of somatic mutations and viral mutations by inducing the imbalance between the mutagenic forces such as cytidine deaminases and mutation-correcting forces including uracil–DNA glycosylase. Most cells with somatic mutations and mutated viruses are eliminated in survival competition. Only a small percentage of mutated cells survive, adapt to the hostile environment, retro-differentiate, and function as cancer-initiating cells via altering signaling pathways. These cancer-initiating cells acquire stem-ness, reprogram metabolic patterns, and affect the microenvironment. The carcinogenic process follows the law of “mutation-selection-adaptation”. Chronic physical activity reduces the levels of inflammation via upregulating the activity and numbers of NK cells and lymphocytes and lengthening leukocyte telomere(definition); downregulating proinflammatory cytokines including interleukin-6 and senescent lymphocytes especially in aged population. Anti-inflammation medication reduces the occurrence and recurrence of cancers. Targeting cancer stemness signaling pathways might lead to cancer eradication. Cancer Evo-Dev not only helps understand the mechanisms by which inflammation promotes the development of cancers, but also lays the foundation for effective prophylaxis and targeted therapy of various cancers.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fimmu.2021.768098
Canonical
link ↗
Fetched
2026-09-04 MST

Cite this

APA
Liu, W., Deng, Y., Li, Z., Chen, Y., Zhu, X., Tan, X., &amp; Cao, G. (2021). Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2021.768098
Vancouver
Liu W, Deng Y, Li Z, Chen Y, Zhu X, Tan X, et al. Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis. Frontiers in Immunology. 2021. doi:10.3389/fimmu.2021.768098.
BibTeX
@article{wenbin2021Cancer, title = {Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis}, author = {Wenbin Liu and Yang Deng and Zishuai Li and Yifan Chen and Xiaoqiong Zhu and Xiaojie Tan and Guangwen Cao}, journal = {Frontiers in Immunology}, year = {2021}, doi = {10.3389/fimmu.2021.768098}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings